AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/141
COLLECTION OF MORE HEMATOPOIETIC PROGENITOR CELLS WITH LARGE-VOLUME LEUKAPHERESIS IN PATIENTS WITH MULTIPLE-MYELOMA
Authors: DESIKAN KR JAGANNATH S SIEGEL D NELSON J BRACY D BARLOGIE B TRICOT G
Citation: Kr. Desikan et al., COLLECTION OF MORE HEMATOPOIETIC PROGENITOR CELLS WITH LARGE-VOLUME LEUKAPHERESIS IN PATIENTS WITH MULTIPLE-MYELOMA, Leukemia & lymphoma, 28(5-6), 1998, pp. 501-508
COMPARABLE ENGRAFTMENT KINETICS FOLLOWING PERIPHERAL-BLOOD STEM-CELL INFUSION MOBILIZED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR WITH OR WITHOUT CYCLOPHOSPHAMIDE IN MULTIPLE-MYELOMA
Authors: DESIKAN KR BARLOGIE B JAGANNATH S VESOLE DH SIEGEL D FASSAS A MUNSHI N SINGHAL S MEHTA J TINDLE S NELSON J BRACY D MATTOX S TRICOT G
Citation: Kr. Desikan et al., COMPARABLE ENGRAFTMENT KINETICS FOLLOWING PERIPHERAL-BLOOD STEM-CELL INFUSION MOBILIZED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR WITH OR WITHOUT CYCLOPHOSPHAMIDE IN MULTIPLE-MYELOMA, Journal of clinical oncology, 16(4), 1998, pp. 1547-1553
DOUBLE AUTOTRANSPLANTS (DAT) FOR 542 PATIENTS WITH MULTIPLE-MYELOMA (MM)
Authors: BARLOGIE B TRICOT G DESIKAN KR SIEGEL D MEHTA J SINGHAL S JAGANNATH S
Citation: B. Barlogie et al., DOUBLE AUTOTRANSPLANTS (DAT) FOR 542 PATIENTS WITH MULTIPLE-MYELOMA (MM), Bone marrow transplantation, 22, 1998, pp. 5-5
SALVAGE AUTOLOGOUS OR ALLOGENEIC TRANSPLANTATION FOR MULTIPLE-MYELOMAREFRACTORY TO OR RELAPSING AFTER A FIRST-LINE AUTOGRAFT
Authors: MEHTA J TRICOT G JAGANNATH S AYERS D SINGHAL S SIEGEL D DESIKAN K MUNSHI N FASSAS A MATTOX S VESOLE D CROWLEY J BARLOGIE B
Citation: J. Mehta et al., SALVAGE AUTOLOGOUS OR ALLOGENEIC TRANSPLANTATION FOR MULTIPLE-MYELOMAREFRACTORY TO OR RELAPSING AFTER A FIRST-LINE AUTOGRAFT, Bone marrow transplantation, 21(9), 1998, pp. 887-892
LONG-TERM FOLLOW-UP AFTER HIGH-DOSE THERAPY FOR HIGH-RISK MULTIPLE-MYELOMA
Authors: BARLOGIE B JAGANNATH S NAUCKE S MATTOX S BRACY D CROWLEY J TRICOT G ALEXANIAN R
Citation: B. Barlogie et al., LONG-TERM FOLLOW-UP AFTER HIGH-DOSE THERAPY FOR HIGH-RISK MULTIPLE-MYELOMA, Bone marrow transplantation, 21(11), 1998, pp. 1101-1107
A MULTICENTER STUDY OF PLATELET RECOVERY AND UTILIZATION IN PATIENTS AFTER MYELOABLATIVE THERAPY AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION
Authors: BERNSTEIN SH NADEMANEE AP VOSE JM TRICOT G FAY JW NEGRIN RS DIPERSIO J RONDON G CHAMPLIN R BARNETT MJ CORNETTA K HERZIG GP VAUGHAN W GEILS G KEATING J MESSNER H WOLFF SN MILLER KB LINKER C CAIRO M HELLMANN S ASHBY M STRYKER S NASH RA
Citation: Sh. Bernstein et al., A MULTICENTER STUDY OF PLATELET RECOVERY AND UTILIZATION IN PATIENTS AFTER MYELOABLATIVE THERAPY AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Blood, 91(9), 1998, pp. 3509-3517
OLIGOCLONAL PROTEIN BANDS AND IG ISOTYPE SWITCHING IN MULTIPLE-MYELOMA TREATED WITH HIGH-DOSE THERAPY AND HEMATOPOIETIC-CELL TRANSPLANTATION
Authors: ZENT CS WILSON CS TRICOT G JAGANNATH S SIEGEL D DESIKAN KR MUNSHI N BRACY D BARLOGIE B BUTCH AW
Citation: Cs. Zent et al., OLIGOCLONAL PROTEIN BANDS AND IG ISOTYPE SWITCHING IN MULTIPLE-MYELOMA TREATED WITH HIGH-DOSE THERAPY AND HEMATOPOIETIC-CELL TRANSPLANTATION, Blood, 91(9), 1998, pp. 3518-3523
JUMPING TRANSLOCATIONS OF CHROMOSOME 1Q IN MULTIPLE-MYELOMA - EVIDENCE FOR A MECHANISM INVOLVING DECONDENSATION OF PERICENTROMERIC HETEROCHROMATIN
Authors: SAWYER JR TRICOT G MATTOX S JAGANNATH S BARLOGIE B
Citation: Jr. Sawyer et al., JUMPING TRANSLOCATIONS OF CHROMOSOME 1Q IN MULTIPLE-MYELOMA - EVIDENCE FOR A MECHANISM INVOLVING DECONDENSATION OF PERICENTROMERIC HETEROCHROMATIN, Blood, 91(5), 1998, pp. 1732-1741
COLLECTION, TUMOR CONTAMINATION, AND ENGRAFTMENT KINETICS OF HIGHLY PURIFIED HEMATOPOIETIC PROGENITOR CELLS TO SUPPORT HIGH-DOSE THERAPY INMULTIPLE-MYELOMA
Authors: TRICOT G GAZITT Y LEEMHUIS T JAGANNATH S DESIKAN KR SIEGEL D FASSAS A TINDLE S NELSON J JUTTNER C TSUKAMOTO A HALLAGAN J ATKINSON K READING C HOFFMAN R BARLOGIE B
Citation: G. Tricot et al., COLLECTION, TUMOR CONTAMINATION, AND ENGRAFTMENT KINETICS OF HIGHLY PURIFIED HEMATOPOIETIC PROGENITOR CELLS TO SUPPORT HIGH-DOSE THERAPY INMULTIPLE-MYELOMA, Blood, 91(12), 1998, pp. 4489-4495
INCIDENCE AND IMPACT OF LIGHT-CHAIN ASSOCIATED (AL) AMYLOIDOSIS ON THE PROGNOSIS OF PATIENTS WITH MULTIPLE-MYELOMA TREATED WITH AUTOLOGOUS TRANSPLANTATION
Authors: DESIKAN KR DHODAPKAR MV HOUGH A WALDRON T JAGANNATH S SIEGEL D BARLOGIE B TRICOT G
Citation: Kr. Desikan et al., INCIDENCE AND IMPACT OF LIGHT-CHAIN ASSOCIATED (AL) AMYLOIDOSIS ON THE PROGNOSIS OF PATIENTS WITH MULTIPLE-MYELOMA TREATED WITH AUTOLOGOUS TRANSPLANTATION, Leukemia & lymphoma, 27(3-4), 1997, pp. 315-319
TREATMENT OF AL-AMYLOIDOSIS WITH DEXAMETHASONE PLUS ALPHA-INTERFERON
Authors: DHODAPKAR MV JAGANNATH S VESOLE D MUNSHI N NAUCKE S TRICOT G BARLOGIE B
Citation: Mv. Dhodapkar et al., TREATMENT OF AL-AMYLOIDOSIS WITH DEXAMETHASONE PLUS ALPHA-INTERFERON, Leukemia & lymphoma, 27(3-4), 1997, pp. 351-356
AUTOTRANSPLANTS IN MULTIPLE-MYELOMA - PUSHING THE ENVELOPE
Authors: JAGANNATH S TRICOT G BARLOGIE B
Citation: S. Jagannath et al., AUTOTRANSPLANTS IN MULTIPLE-MYELOMA - PUSHING THE ENVELOPE, Hematology/oncology clinics of North America, 11(2), 1997, pp. 363
CYTOGENETICS AND MOLECULAR-GENETICS IN MULTIPLE-MYELOMA
Authors: FEINMAN R SAWYER J HARDIN J TRICOT G
Citation: R. Feinman et al., CYTOGENETICS AND MOLECULAR-GENETICS IN MULTIPLE-MYELOMA, Hematology/oncology clinics of North America, 11(1), 1997, pp. 1
UNIQUE ROLE OF CYTOGENETICS IN THE PROGNOSIS OF PATIENTS WITH MYELOMARECEIVING HIGH-DOSE THERAPY AND AUTOTRANSPLANTS
Authors: TRICOT G SAWYER JR JAGANNATH S DESIKAN KR SIEGEL D NAUCKE S MATTOX S BRACY D MUNSHI N BARLOGIE B
Citation: G. Tricot et al., UNIQUE ROLE OF CYTOGENETICS IN THE PROGNOSIS OF PATIENTS WITH MYELOMARECEIVING HIGH-DOSE THERAPY AND AUTOTRANSPLANTS, Journal of clinical oncology, 15(7), 1997, pp. 2659-2666
FEASIBILITY AND COST-EFFECTIVENESS OF OUTPATIENT AUTOTRANSPLANTS IN MULTIPLE-MYELOMA
Authors: JAGANNATH S VESOLE DH ZHANG M DESIKAN KR COPELAND N JAGANNATH M BRACY D JONES R CROWLEY J TRICOT G BARLOGIE B
Citation: S. Jagannath et al., FEASIBILITY AND COST-EFFECTIVENESS OF OUTPATIENT AUTOTRANSPLANTS IN MULTIPLE-MYELOMA, Bone marrow transplantation, 20(6), 1997, pp. 445-450
HIGH-DOSE CHEMOTHERAPY WITH CARBOPLATIN, CYCLOPHOSPHAMIDE AND ETOPOSIDE AND AUTOLOGOUS TRANSPLANTATION FOR MULTIPLE-MYELOMA RELAPSING AFTERA PREVIOUS TRANSPLANT
Authors: MEHTA J TRICOT G JAGANNATH S DESIKAN KR SIEGEL D SINGHAL S MUNSHI N VESOLE D MATTOX S BRACY D BARLOGIE B
Citation: J. Mehta et al., HIGH-DOSE CHEMOTHERAPY WITH CARBOPLATIN, CYCLOPHOSPHAMIDE AND ETOPOSIDE AND AUTOLOGOUS TRANSPLANTATION FOR MULTIPLE-MYELOMA RELAPSING AFTERA PREVIOUS TRANSPLANT, Bone marrow transplantation, 20(2), 1997, pp. 113-116
PERIPHERAL STEM-CELL MOBILIZATION AND ENGRAFTMENT IN PATIENTS OVER AGE 60
Authors: GUBA SC VESOLE DH JAGANNATH S BRACY D BARLOGIE B TRICOT G
Citation: Sc. Guba et al., PERIPHERAL STEM-CELL MOBILIZATION AND ENGRAFTMENT IN PATIENTS OVER AGE 60, Bone marrow transplantation, 20(1), 1997, pp. 1-3
BIOLOGY AND THERAPY OF MULTIPLE-MYELOMA IN 1996
Authors: BARLOGIE B JAGANNATH S EPSTEIN J MUNSHI N SIEGEL D DESIKAN KR FEINMAN R HSU PL VONBREMEN K TRICOT G
Citation: B. Barlogie et al., BIOLOGY AND THERAPY OF MULTIPLE-MYELOMA IN 1996, Seminars in hematology, 34(1), 1997, pp. 67-72
STEM-CELL COLLECTION IN MYELOMA PATIENTS - REPEATED ATTEMPTS MAY BE NEEDED TO OBTAIN AN ADEQUATE HARVEST IN PATIENTS FAILING TO COLLECT WELL INITIALLY
Authors: DESIKAN KR NELSON J TINDLE S SIEGEL D SINGHAL S FASSAS A TRICOT G JAGANNATH S BARLOGIE B MEHTA J
Citation: Kr. Desikan et al., STEM-CELL COLLECTION IN MYELOMA PATIENTS - REPEATED ATTEMPTS MAY BE NEEDED TO OBTAIN AN ADEQUATE HARVEST IN PATIENTS FAILING TO COLLECT WELL INITIALLY, Blood, 90(10), 1997, pp. 4208-4208
AUTOLOGOUS MARROW INFUSION WITHOUT FURTHER CONDITIONING FOR LIFE-THREATENING GVHD - RESOLUTION OF GVHD WITH PERSISTENT DONOR-TYPE CHIMERISM
Authors: MEHTA J SINGHAL S FASSAS A HILTON J SIEGEL D DESIKAN K JAGANNATH S ANAISSIE E BARLOGIE B TRICOT G
Citation: J. Mehta et al., AUTOLOGOUS MARROW INFUSION WITHOUT FURTHER CONDITIONING FOR LIFE-THREATENING GVHD - RESOLUTION OF GVHD WITH PERSISTENT DONOR-TYPE CHIMERISM, Blood, 90(10), 1997, pp. 4422-4422
JUMPING TRANSLOCATIONS OF CHROMOSOME 1Q IN MULTIPLE-MYELOMA - EVIDENCE FOR A MECHANISM INVOLVING DECONDENSATION OF PERICENTROMERIC HETEROCHROMATIN
Authors: SAWYER JR TRICOT G MATTOX S JAGANNATH S BARLOGIE B
Citation: Jr. Sawyer et al., JUMPING TRANSLOCATIONS OF CHROMOSOME 1Q IN MULTIPLE-MYELOMA - EVIDENCE FOR A MECHANISM INVOLVING DECONDENSATION OF PERICENTROMERIC HETEROCHROMATIN, Blood, 90(10), 1997, pp. 391-391
BONE-MARROW MORPHOLOGY (BMM) ADDS CRITICAL PROGNOSTIC INFORMATION TO OTHER STANDARD PARAMETERS (SP) INCLUDING CYTOGENETICS AMONG NEWLY-DIAGNOSED MULTIPLE-MYELOMA (MM) PATIENTS (PTS) RECEIVING TOTAL THERAPY (TT)
Authors: WALDRON J JAZIEH R JAGANNATH S DESIKAN KR SIEGEL D FASSAS A SINGHAL S MEHTA J TRICOT G VESOLE D WILSON C HOUGH A NAUCKE S SPOON D BARLOGIE B
Citation: J. Waldron et al., BONE-MARROW MORPHOLOGY (BMM) ADDS CRITICAL PROGNOSTIC INFORMATION TO OTHER STANDARD PARAMETERS (SP) INCLUDING CYTOGENETICS AMONG NEWLY-DIAGNOSED MULTIPLE-MYELOMA (MM) PATIENTS (PTS) RECEIVING TOTAL THERAPY (TT), Blood, 90(10), 1997, pp. 394-394
CLINICAL-RESULTS OF THYMIDINE KINASE (TK) GENE TRANSDUCED DONOR LYMPHOCYTE INFUSION FOLLOWING ALLOGENEIC TRANSPLANTATION IN MYELOMA
Authors: MUNSHI NC TRICOT G JAGANNATH S MEHTA J DESIKAN K SIEGLE S SINGHAL S FASSAS A FINK L SCHICHMAN S CHIANG Y REYNOLDS C BARLOGIE B
Citation: Nc. Munshi et al., CLINICAL-RESULTS OF THYMIDINE KINASE (TK) GENE TRANSDUCED DONOR LYMPHOCYTE INFUSION FOLLOWING ALLOGENEIC TRANSPLANTATION IN MYELOMA, Blood, 90(10), 1997, pp. 485-485
PROLONGED IMMUNOSUPPRESSION AFTER CD34(+) OR CD34(+) THY-1(+)/LIN(ASTERISK) SELECTED AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTS (TX) FOR MULTIPLE-MYELOMA/
Authors: SIEGEL D MEHTA J ANAISSIE E DESIKAN KR FASSAS A JAGANNATH S SINGHAL S TRICOT G MUNSHI N BARNHART S HOOD S SPOON D MATTOX S BARLOGIE B
Citation: D. Siegel et al., PROLONGED IMMUNOSUPPRESSION AFTER CD34(+) OR CD34(+) THY-1(+)/LIN(ASTERISK) SELECTED AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTS (TX) FOR MULTIPLE-MYELOMA/, Blood, 90(10), 1997, pp. 487-487
HIGH-INCIDENCE OF AND MORTALITY FROM TOXOPLASMA-GONDII INFECTIONS IN T-CELL DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS
Authors: KONERU B ANAISSIE E TRICOT G JAGANNATH S MEHTA J DESIKAN R SIEGEL D SINGHAL S FASSAS A BARLOGIE B
Citation: B. Koneru et al., HIGH-INCIDENCE OF AND MORTALITY FROM TOXOPLASMA-GONDII INFECTIONS IN T-CELL DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS, Blood, 90(10), 1997, pp. 987-987
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>